Surgery for hemophilia in developing countries

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 5, 2005, Pages 538-543

  Mathews, Vikram ^a   Viswabandya, Auro ^a   Baidya, Shoma ^a   George, Biju ^a   Nair, Sukesh ^a   Chandy, Mammen ^a   Srivastava, Alok ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Developing world; Hemophilia; Low dose protocols; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; FIBRIN GLUE; FRESH FROZEN PLASMA; GENTAMICIN; PROTEIN A; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8;

BLEEDING; BLOOD COMPONENT THERAPY; CRYOPRECIPITATE; DEVELOPING COUNTRY; DRUG INTERMITTENT THERAPY; ELECTIVE SURGERY; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; INDIA; LOW DRUG DOSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

BLOOD COAGULATION FACTORS; DEVELOPING COUNTRIES; HEMOPHILIA A; HEMORRHAGE; HUMANS; INDIA; PREMEDICATION; SURGICAL PROCEDURES, OPERATIVE;

EID: 27844592636     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-922225     Document Type: Review

References (20)

1. Srivastava A. Choice of factor concentrates for haemophilia: a developing world perspective. Haemophilia 2001;7:117-122
2. Srivastava A. Factor replacement therapy in haemophilia - are there models for developing countries? Haemophilia 2003; 9:391-396
3. Rickard K. Guidelines for therapy and optimal dosage of coagulation for the treatment of bleeding and surgery in haemophilia. Haemophilia 1995;1(suppl 1):8-13
4. Bhushan V, Chandy M, Khanduri U, Dennison D, Srivastava A, Apte S. Surgery in patients with congenital coagulation disorders. Natl Med J India 1994;7:8-12
5. Kasper CK. Hemophilia of Georgia, USA. Protocols for the treatment of haemophilia and von Willebrand disease. Haemophilia 2000;6(suppl 1):84-93
6. Kasper CK, Boylen AL, Ewing NP, Luck JV Jr, Dietrich SL. Hematologic management of hemophilia A for surgery. JAMA 1985;253:1279-1283
7. Srivastava A, Chandy M, Sunderaj GD, et al. Low-dose intermittent factor replacement for post-operative haemostasis in haemophilia. Haemophilia 1998;4:799-801
8. Martinowitz UP, Schulman S. Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B. Acta Haematol 1995;94(suppl 1):35-42
9. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia 1999;5:253-259
10. Di Michele DM. Immune tolerance: a synopsis of the international experience. Haemophilia 1998;4:568-573
11. Rivard GE. Use of protein-A column and porcine factor VIII. Haemophilia 2002;8(suppl 1):20-23, discussion 28-32
12. Preston FE, Dinsdale RC, Sutcliffe DJ, Bardhan G, Wyld PJ, Hamlyn JF. Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors. Thromb Res 1977;11:643-651
13. Rasche H, Bindewald H, Kohle W, Scheck R, Heinrich R, Seibert K. Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates. [Author's translation]. Dtsch Med Wochenschr 1977; 102:319-323
14. Thomas T, Williams H, Williams Y, Hunt J. FEIBA in haemophiliacs with factor VIII inhibitor. BMJ 1977; 1:52
15. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997;77:1113-1119
16. Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000;110:715-720
17. Rochat C, McFadyen ML, Schwyzer R, Gillham A, Cruickshank A. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery. Haemophilia 1999;5:181-186
18. Campbell PJ, Rickard KA. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience. Aust N Z J Med 1998;28:440-445
19. Hay CR, Doughty HI, Savidge GF. Continuous infusion of factor VIII for surgery and major bleeding. Blood Coagul Fibrinolysis 1996;7(suppl 1):S15-S19
20. Morfini M, Messori A, Longo G. Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion. Blood Coagul Fibrinolysis 1996;7(suppl 1):S11-S14